In liver cancer cells, nuclear PHGDH interacts with nuclear c-Myc to form a complex, which drives the expression of CXCL1 and IL-8 via the PHGDH/p300/c-Myc/AF9 transactivation axis. Here, PHGDH is linked to liver cancer.